Clinical outcome at discharge and after 6 months
| RT | Stent-assisted | Total | |
|---|---|---|---|
| Clinical outcome at discharge | |||
| mRS 0–1 | 143/146 (97.9%) | 111/114 (97.3%) | 254/260 (97.6%) |
| mRS 2–5 | 3/146 (2.1%) | 3/114 (2.7%) | 6/260 (2.4%) |
| Clinical outcome after 6 months | |||
| mRS 0–1 | 140/143 (97.9%) | 98/100 (98%) | 238/243 (98%) |
| mRS 2–5 | 3/143 (2.1%) | 2/100 (2%) | 5/243 (2%) |
| Mortality | 4/150 (2.6%) | 2/116 (1.7%) | 6/268 (2.2%) |
| Adverse events | |||
| Total (any mRS) | 14/151 (9.3%) | 12/117 (10.3%) | 26/268 (9.7%) |
| Ischemic mRS ≥2 | 1/151 (0.6%) | 1/117 (0.8%) | 2/268 (0.7%) |
| Hemorrhagic mRS ≥2 | 7/151 (4.6%) | 4/117 (3.4%) | 11/268 (4.1%) |
mRS, modified Rankin Scale; RT, remodeling technique.